What's new - What's changing in prostate cancer?

Friday 17 February 2012

Venue: Royal Society of Medicine, 1 Wimpole Street, LONDON, W1G 0AE

A joint meeting with The British Uro-oncology Group

Registration for this event is now closed, unfortunately no more places are available.

The RSM and BUG will provide a highly interactive, educational meeting on the spectrum of prostate cancer: diagnosis, assessment, management and new developments in the field. The one day meeting is for trainees, junior consultants, nurses, radiographers and other colleagues who will learn about or consolidate their knowledge on the latest practice across all stages of the disease.


Registration Details:
Consultant/GP: Free of charge
RSM Retired Fellow: Free of charge
RSM Student: Free of charge
RSM Trainee: Free of charge
RSM Associate: Free of charge
RSM Fellow: Free of charge
Student: Free of charge
Trainee: Free of charge
AHP/Nurse/Midwife: Free of charge


8.30 am

Registration, tea, coffee and exhibition
Chair: Dr Simon Hughes, Consultant Clinical Oncologist, Guy's & St Thomas', London
Dr Heather Payne, Consultant Clinical Oncologist, University College Hospital, London

9.20 am

Chairs' welcome

Diagnosis and staging

9.30 am

The screening debate
Mr John Anderson, Consultant
Urological Surgeon, Royal Hallamshire
Hospital, Sheffield

9.45 am

New markers
Dr Hayley Whitaker, Research Associate, Cambridge Cancer Centre, Cambridge

10.00 am

Pathology
Alex Freeman, Consultant Histopathologist, University College Hospital, London

10.15 am

Radiology
Dr Clare Allen, Consultant in Radiology, University College Hospital, London

10.30 am

Discussion

10.45 am

Tea, coffee and exhibition

Localised prostate cancer

11.00 am

Active surveillance
Dr Zafar Malik, Consultant Clinical Oncologist, Clatterbridge Centre for Oncology, Wirral

11.15 am

Robots
Mr Ben Challacombe, Consultant Urologist, Guy's & St Thomas', London

11.30 am

Brachytherapy
Dr Robert Laing, Consultant Clinical Oncologist, Royal Surrey County Hospital, Surrey

11.45 pm

Radiotherapy - New advances
Prof David Dearnaley, Professor Uro-Oncology, Royal Marsden Hospital, Sutton

12.00 pm

Challenging cases and MDT debate
All

12.30 pm

Lunch and exhibition - posters

1.30 pm

Results of poster judging

Locally advanced disease

1.45 pm

Neoadjuvant and adjuvant hormone therapy
Dr Heather Payne, Consultant Clinical Oncologist, University College Hospital, London

2.00 pm

Management of local recurrence after radiotherapy and surgery
Dr Simon Hughes, Consultant Clinical Oncologist, Guy's & St Thomas', London

2.15 pm

Challenging cases and MDT debate
All

2.45 pm

Tea, coffee and exhibition

Advanced disease

3.00 pm

Hormone therapy
Dr Amit Bahl, Consultant Clinical Oncologist, Bristol Haematology & Oncology Centre, Bristol

3.15 pm

Chemotherapy
Dr Simon Chowdhury, Consultant Medical Oncologist, Guy's & St Thomas', London

3.30 pm

Palliative care
Dr Chris Farnham, Consultant in Palliative Medicine, St John and St Elizabeth Hospice, London

3.45 pm

Challenging cases and MDT debate
All

4.15 pm

The future of MDTs
Mr James Green, Consultant Urological Surgeon, Whipps Cross University Hospital, London
Mr Ben Lamb, Clinical Research Fellow Imperial College and Whipps Cross University Hospital, London

4.45 pm

Completion of evaluation forms and close of meeting

Meeting ref: OCC03

CPD (Applied for)


Amgen    Astra Zeneca    Ferring Pharmaceuticals

Ipsen    Janssen    Sanofi Aventis

More about this section

Contact:
Tel: +44 (0) 20 7290 3942
Fax: +44 (0) 20 7290 2989
Email: Coordinator